Ładuje się......
Genes and resistance to disease /
The advances in human genetics that have ocurred during the past 20 years have revolutionized our knowledge of the role played by inheritance in health and disase. It is clear that our DNA determines not only the emergence of catastrophic single-gene disorders, which affect millions of persons world...
| organizacja autorów: | , |
|---|---|
| Kolejni autorzy: | , , |
| Format: | Printed Book |
| Język: | English |
| Wydane: |
Berlin ; New York :
Springer,
c2000.
|
| Hasła przedmiotowe: |
| LEADER | 02464cam a22003974a 4500 | ||
|---|---|---|---|
| 003 | 0 | ||
| 008 | 000210s2000 gw a b 101 0 eng c | ||
| 010 | |a 00023232 | ||
| 020 | |a 3540667245 (hardcover : alk. paper) | ||
| 035 | |a (DNLM)100930071 | ||
| 042 | |a pcc | ||
| 060 | 1 | 0 | |a QZ 50 |b G3218 2000 |
| 082 | 0 | 0 | |a 616.042 |2 21 |
| 245 | 0 | 0 | |a Genes and resistance to disease / |c V. Boulyjenkov, K. Berg, Y. Christen (eds.) |
| 260 | |a Berlin ; |a New York : |b Springer, |c c2000. | ||
| 300 | |a xii, 180 p. : |b ill. (some col.) ; |c 24 cm. | ||
| 504 | |a Includes bibliographical references and index. | ||
| 520 | |a The advances in human genetics that have ocurred during the past 20 years have revolutionized our knowledge of the role played by inheritance in health and disase. It is clear that our DNA determines not only the emergence of catastrophic single-gene disorders, which affect millions of persons worldwide, but also interacts with environments to predispose individuals to cancer, allergy, hypertension, heart disease, diabetes, psychiatric disorders and even to some infectious diseases. Overall, the study of longevity and the demonstration of genes favouring a long lifespan suggest that such protective systems exist. In recent years, the study of genetic polymorphisms has made clear that some alleles have beneficial effects. These discoveries can substantially improve our understanding of the interactions between genetics and the environment, between pathogenetic mechanisms and new treatments. | ||
| 650 | 0 | |a Genes |v Congresses. | |
| 650 | 0 | |a Immunogenetics |v Congresses. | |
| 650 | 0 | |a Medical genetics |v Congresses. | |
| 650 | 0 | |a Natural immunity |v Congresses. | |
| 650 | 1 | 2 | |a Genetics, Medical |v Congresses. |
| 650 | 2 | 2 | |a Gene Therapy |v Congresses. |
| 650 | 2 | 2 | |a Immunity, Natural |v Congresses. |
| 700 | 1 | |a Berg, Kåre. | |
| 700 | 1 | |a Boulyjenkov, V. | |
| 700 | 1 | |a Christen, Yves. | |
| 710 | 2 | |a Fondation IPSEN pour la recherche thérapeutique. | |
| 710 | 2 | |a World Health Organization. | |
| 906 | |a 7 |b cbc |c orignew |d 1 |e ocip |f 20 |g y-gencatlg | ||
| 942 | |2 ddc |c BK | ||
| 955 | |a DEOF fixed; ta00 2002-05-24 | ||
| 955 | |a to NLM pc05 02-10-00; yk05 to ASCD 02-25-00; jc02 to technician 02-28-00; jc03 to Dewey 02-29-00; aa05 03-01-00; jc03 CIP ver. and to BCCD 08-15-00 | ||
| 999 | |c 152772 |d 152772 | ||
| 952 | |0 0 |1 0 |2 ddc |4 0 |6 616_042000000000000_BOU_G |7 0 |9 163290 |a BIO |b BIO |c ST1 |d 2014-05-22 |i 829 |l 0 |o 616.042 BOU/ G |p BIO829 |r 2014-05-22 |w 2014-05-22 |y BK | ||